As for the effect of Gal-3 expression on the survival of PCa patients, both the results of this study (Figure 5), and those of the exploratory analysis using UALCAN and GEPIA, showed that this effect was not statistically significant (p = 0.79; p = 0.74) (Figure 6D and Figure 7B). This evidence concerns the gene LGALS3 and posterior cortical atrophy.